Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen
Condition(s):Aging-related Inflammation in HIV-infected PatientsLast Updated:October 29, 2020Completed